Άνω των 380 πλήρων δημοσιεύσεων σε περιοδικά του εξωτερικού μετά από κρίση

Katsambas A., Graupe, K., Stratigos, J.

Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin

(1989) Acta Dermato-Venereologica, Supplement, 69 (143), pp. 35-39

Katsambas, A.D.

Why and when the treatment of acne fails. What to do

(1998) Dermatology, 196 (1), pp. 158-161

Clark, S.M., Cunliffe, W.J., Katsambas, A.D.

Childhood/adolescent acne: A review of aetiology and management

(1999) Current Paediatrics, 9 (1), pp. 1-6

Katsambas, A.D., Nicolaidou, E.

Acne, perioral dermatitis, flushing, and rosacea: Unapproved treatments or indications

(2000) Clinics in Dermatology, 18 (2), pp. 171-176

Papageorgiou, P., Katsambas, A., Chu, A.C.

Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris

(2000) British Journal of Dermatology, 142 (5), pp. 973-978

Ioannides, D., Rigopoulos, D., Katsambas, A.

Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: A randomized open-label clinical trial

(2002) British Journal of Dermatology, 147 (3), pp. 523-527

Ross, J.I., Snelling, A.M., Carnegie, E., Coates, P., Cunliffe, W.J., Bettoli, V., Tosti, G., Katsambas, A., Galvan Peréz Del Pulgar, J.I., Rollman, O., Török, L., Eady, E.A., Cove, J.H.

Antibiotic-resistant acne: Lessons from Europe

(2003) British Journal of Dermatology, 148 (3), pp. 467-478

Katsambas, A., Papakonstantinou, A.

Acne: Systemic treatment

(2004) Clinics in Dermatology, 22 (5), pp. 412-418

Katsambas, A.D., Stefanaki, C., Cunliffe, W.J.

Guidelines for treating acne

(2004) Clinics in Dermatology, 22 (5), pp. 439-444

Katsambas, A.D., Cunliffe, W.J.

Commentary: Acne and its treatment

(2004) Clinics in Dermatology, 22 (5), p. 359

Katsambas, A.D.

RALGA (Diacnéal®), a retinaldehyde and glycolic acid association and postinflammatory hyperpigmentation in acne – A review

(2005) Dermatology, 210 (SUPPL. 1), pp. 39-45.

Stefanaki, I., Katsambas, A.D.

What to do when acne treatments fail.

(2006) Giornale Italiano di Dermatologia e Venereologia, 141 (1), pp. 63-68

Katsambas, A., Dessinioti, C.

New and emerging treatments in dermatology: Acne

(2008) Dermatologic Therapy, 21 (2), pp. 86-95

Antoniou, C., Dessinioti, C., Stratigos, A.J., Katsambas, A.D.

Clinical and therapeutic approach to childhood acne: An update

(2009) Pediatric Dermatology, 26 (4), pp. 373-380

Katsambas, A.D., Dessinioti, C.

Hormonal therapy for acne: why not as first line therapy? Facts and controversies

(2010) Clinics in Dermatology, 28 (1), pp. 17-23

Rigopoulos, D., Larios, G., Katsambas, A.D.

The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies

(2010) Clinics in Dermatology, 28 (1), pp. 24-30.

Preneau, S., Dessinioti, C., Nguyen, J.-M., Katsambas, A., Dreno, B.

Predictive markers of response to isotretinoin in female acne

(2013) European Journal of Dermatology, 23 (4), pp. 478-486

Dessinioti, C., Antoniou, C., Katsambas, A.

Acneiform eruptions

(2014) Clinics in Dermatology, (32) 1, pp. 24-34

Dessinioti, C., Katsambas, A., Antoniou, C

Hidradenitis suppurrativa (acne inversa) as a systemic disease

(2014) Clinics in Dermatology, (32) 3, pp. 397-408

Lucky, A.W., Dessinioti, C., Katsambas, A.

Adult acne (book chapter)

(2014) Pathogenesis and Treatment of Acne and Rosacea (9783540693758) 1, pp. 243-249

Katsambas, A., Dessinioti, C.

Adult neonatorum (book chapter)

(2014) Pathogenesis and Treatment of Acne and Rosacea (9783540693758) 1, pp. 283-289

Katsambas, A., Dessinioti, C., Cunliffe, W.J.

Clinical aspects of acne fulminans (book chapter)

(2014) Pathogenesis and Treatment of Acne and Rosacea (9783540693758) 1, pp. 223 – 226

Katsambas, A., Dessinioti, C., Cunliffe, W.J.

Clinical aspects of acne vulgaris (book chapter)

(2014) Pathogenesis and Treatment of Acne and Rosacea (9783540693758) 1, pp. 213-221

Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M.

European handbook of dermatological treatments, third edition

(2015) Pages 1-1579

Katsambas, A., Dessinioti, C.

The changing faces of acne, rosacea, and hidradenitis suppurativa (Editorial)

(2017) Clinics in Dermatology, (35) 2, pp. 115-117

Pavlidis, A.I., Katsambas, A.D.

Therapeutic approaches to reducing atrophic acne scarring (Article)

(2017) Clinics in Dermatology, (35) 2, pp. 190 -194

Dessinioti, C., Katsambas, A.

Propionibacterium acnes and antimicrobial resistance in acne (Article)

(2017) Clinics in Dermatology, (35) 2, pp. 163 – 167

Kosmadaki, M., Katsambas, A.

Topical treatments for acne (Article)

(2017) Clinics in Dermatology, (35) 2, pp. 173 – 178

Dessinioti, C., Katsambas, A.

Difficult and rare forms of acne (Article)

(2017) Clinics in Dermatology, (35) 2, pp. 138 – 146

Dessinioti, C., Platsidaki, E., Zisimou, C., Tzanetakou, V., Katsambas, A., Antoniou, C.

A cross-sectional study of the perceptions about triggering factors in acne patients (Letter)

(2018) Journal of the European Academy of Dermatology and Venereology, (32) 4, pp. 137-139

Dessinioti, C., Zisimou, C., Platsidaki, E., Katsambas, A., Antoniou, C.

A cross-sectional study of clinical factors associated with acne facial scarring in patients with active acne (Letter)

(2018) Journal of the European Academy of Dermatology and Venereology, (32) 6, pp. 212 – 214

Dessinioti, C., Tzanetakou, V., Zisimou, C., Platsidaki, E., Koukkou, E., Katsambas, A., Antoniou, C.

A study of androgenic signs and disorders in Greek female patients with acne (Letter)

(2018) Journal of the European Academy of Dermatology and Venereology, (32) 7, pp. 279 – 282

Griffiths, C.E.M., Dubertret, L., Ellis, C.N., Finlay, A.Y., Finzi, A.F., Ho, V.C., Johnston, A., Katsambas, A., Lison, A.-E., Naeyaert, J.M., Nakagawa, H., Paul, C., Vanaclocha, F.

Ciclosporin in psoriasis clinical practice: An international consensus statement

(2004) British Journal of Dermatology, Supplement, 150 (67), pp. 11-23

Sterry, W., Barker, J., Boehncke, W.-H., Bos, J.D., Chimenti, S., Christophers, E., De La Brassinne, M., Ferrandiz, C., Griffiths, C., Katsambas, A., Kragballe, K., Lynde, C., Menter, A., Ortonne, J.-P., Papp, K., Prinz, J., Rzany, B., Ronnevig, J., Saurat, J.-H., Stahle, M., Stengel, F.M., Van De Kerkhohf, P., Voorhees, J.

Biological therapies in the systemic management of psoriasis: International Consensus Conference

(2004) British Journal of Dermatology, Supplement, 151 (69), pp. 3-17

Boehncke, W.-H., Brasie, R.A., Barker, J., Chimenti, S., Daudén, E., De Rie, M., Dubertret, L., Giannetti, A., Katsambas, A., Kragballe, K., Naeyaert, J.M., Ortonne, J.-P., Peyrí, J., Prinz, J.C., Saurat, J.-H., Strohal, R., Van De Kerkhof, P., Sterry, W.

Recommendations for the use of etanercept in psoriasis: A European dermatology expert group consensus

(2006) Journal of the European Academy of Dermatology and Venereology, 20 (8), pp. 988-998

Antoniou, C., Stefanaki, I., Stratigos, A., Avgerinou, G., Stavropoulos, P., Potouridou, I., Polidorou, D., Moustou, A.E., Kosmadaki, M., Katsambas, A.D.

The Greek experience with efalizumab in psoriasis from a university dermatologic hospital

(2007) British Journal of Dermatology, 156 (SUPPL. 2), pp. 12-16

Antoniou, C., Dessinioti, C., Katsambas, A., Stratigos, A.J.

Elevated triglyceride and cholesterol levels after intravenous antitumour necrosis factor-α therapy in a patient with psoriatic arthritis and psoriasis vulgaris [27]

(2007) British Journal of Dermatology, 156 (5), pp. 1090-1091

Chaidemenos, G.C., Mourellou, O., Avgoustinaki, N., Papakonstantinou, M., Karakatsanis, G., Katsambas, A.

Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis

(2007) Journal of the European Academy of Dermatology and Venereology, 21 (9), pp. 1203-1208.

Katsambas, A.

Treating psoriasis as a chronic inflammatory systemic disease.

(2008) The British journal of dermatology, 159 Suppl 2, p. 1

Reich, K., Griffiths, C., Barker, J., Chimenti, S., Daudén, E., Giannetti, A., Gniadecki, R., Katsambas, A., Langley, R., Mrowietz, U., Ogilvie, A., Ortonne, J.-P., Reider, N., Saurat, J.-H.

Recommendations for the long-term treatment of psoriasis with infliximab: A dermatology expert group consensus

(2008) Dermatology, 217 (3), pp. 268-275

Antoniou, C., Dessinioti, C., Stratigos, A., Avgerinou, G., Stavropoulos, P., Katsambas, A.

Etanercept in severe, recalcitrant psoriasis: Clinical response, safety profile and predictors of response based on a single institution's experience

(2009) Journal of the European Academy of Dermatology and Venereology, 23 (8), pp. 979-982

Rigopoulos, D., Gregoriou, S., Daniel III, C.R., Belyayeva, H., Larios, G., Verra, P., Stamou, C., Kontochristopoulos, G., Avgerinou, G., Katsambas, A.

Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment

(2009) Dermatology, 218 (4), pp. 338-341.

Katsambas, A., Peris, K., Vena, G., Freidmann, P., Wozel, G., Daudén, E., Licu, D., Placchi, M., De La Brassinne, M.

Assessing the impact of efalizumab on nail, scalp and palmoplantar psoriasis and on quality of life: Results from a multicentre, open-label, phase IIIb/IV trial

(2009) Archives of Drug Information, 2 (4), pp. 66-70.

Antoniou, C., Stefanaki, I., Stratigos, A., Moustou, E., Vergou, T., Stavropoulos, P., Avgerinou, G., Rigopoulos, D., Katsambas, A.D.

Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre

(2010) British Journal of Dermatology, 162 (5), pp. 1117-1123

Ståhle, M., Atakan, N., Boehncke, W.-H., Chimenti, S., Daudén, E., Giannetti, A., Hoeger, P., Joly, P., Katsambas, A., Kragballe, K., Lambert, J., Ortonne, J.-P., Prinz, J.C., Puig, L., Seyger, M., Strohal, R., Van De Kerkhoff, P., Sterry, W.

Juvenile psoriasis and its clinical management: A European expert group consensus

(2010) JDDG – Journal of the German Society of Dermatology, 8 (10), pp. 812-819

Antoniou, C., Dessinioti, C., Vergou, T, Stratigos, A.J, Avgerinou, G, Kostaki, M, Katsambas, A.

Sequential treatment with biologics: Switching from efalizumab to etanercept in 35 patients with high-need psoriasis

(2010) Journal of the European Academy of Dermatology and Venereology, 24 (12), pp. 1413-1420.

Lotti, T., Chimenti, S., Katsambas, A., Ortonne, J.-P., Dubertret, L., Licu, D., Simon, J.

Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial

(2010) Archives of Drug Information, 3 (1), pp. 9-18.

Stefanaki, C., Lagogianni, E., Kontochristopoulos, G., Verra, P., Barkas, G., Katsambas, A., Katsarou, A.

Psoriasis in children: A retrospective analysis

(2011) Journal of the European Academy of Dermatology and Venereology, 25 (4), pp. 417-421

Dessinioti, C., Stefanaki, I., Stratigos, A.J., Kostaki, M., Katsambas, A., Antoniou, C.

Pregnancy during adalimumab use for psoriasis

(2011) Journal of the European Academy of Dermatology and Venereology, 25 (6), pp. 738-739.

Kerkhof, P.V.D., Barker, J., Griffiths, C.E.M., Menter, A., Leonardi, C., Young, M., Kemeny, L., Pincelli, C., Bachelez, H., Katsambas, A., Ståhle, M., Horn, E.J., Sterry, W.

Improving clinical trial design in psoriasis: Perspectives from the global dermatology community

(2011) Journal of Dermatological Treatment, 22 (4), pp. 187-193

Tadros, A., Vergou, T., Stratigos, A.J., Tzavara, C., Hletsos, M., Katsambas, A., Antoniou, C.

Psoriasis: Is it the tip of the iceberg for the quality of life of patients and their families? (Article)

(2011), Journal of the European Academy of Dermatology and Venereology, (25) 11, pp. 1282-1287

Kanelleas, A., Liapi, C., Katoulis, A., Stavropoulos, P., Avgerinou, G., Georgala, S., Economopoulos, T., Stavrianeas, N.G., Katsambas, A.

The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept (Article)

(2011) Clinical and Experimental Dermatology, (36) 8, pp. 845 – 850

Dessinioti, C., Stefanaki, I., Stratigos, A.J., Kostaki, M., Katsambas, A., Antoniou, C.

Pregnancy during adalimumab use for psoriasis (Letter)

(2011) Journal of the European Academy of Dermatology and Venereology, (25) 6, pp. 738 – 739

Kerkhof, P.V.D., Barker, J., Griffiths, C.E.M., Menter, A., Leonardi, C., Young, M., Kemeny, L., Pincelli, C., Bachelez, H., Katsambas, A., Ståhle, M., Horn, E.J., Sterry, W.

Improving clinical trial design in psoriasis: Perspectives from the global dermatology community (Review)

(2011) Journal of Dermatological Treatment, (22) 4, pp. 187 – 193

Tadros, A., Vergou, T., Stratigos, A.J., Tzavara, C., Hletsos, M., Katsambas, A., Antoniou, C.

Psoriasis: Is it the tip of the iceberg for the quality of life of patients and their families? (Article)

(2011) Journal of the European Academy of Dermatology and Venereology, (25) 11, pp. 1282 – 1287

Kanelleas, A., Liapi, C., Katoulis, A., Stavropoulos, P., Avgerinou, G., Georgala, S., Economopoulos, T., Stavrianeas, N.G., Katsambas, A.

The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept (Article)

(2011) Clinical and Experimental Dermatology, (36) 8, pp. 845 – 850

Shear, N.H., Hartmann, M., Toledo-Bahena, M., Katsambas, A., Connors, L., Chang, Q., Yao, R., Nograles, K., Popmihajlov, Z.

Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice (Article)

(2014) British Journal of Dermatology, (171) 3, pp. 631-641

Moustou, A.E., Alexandrou, P., Stratigos, A.J., Giannopoulou, I., Vergou, T., Katsambas, A., Antoniou, C.

Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment (Article)

(2014) Anais Brasileiros de Dermatologia, (89) 6, pp. 891-897

Rigopoulos, D., Katsambas, A., Antoniou, C., Stavrianeas, N.

Malignant tumours of the nail apparatus other than malignant melanoma

(1996) Skin Cancer, 11 (1), pp. 39-43.

Katsambas, A., Nicolaidou, E.

Cutaneous malignant melanoma and sun exposure: Recent developments in epidemiology

(1996) Archives of Dermatology, 132 (4), pp. 444-450

Stratigos, A.J., Yang, G., Dimisianos, R., Nicolaou, V., Stefanaki, I., Katsambas, A.D., Tsao, H.

Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma

(2006) Journal of Investigative Dermatology, 126 (2), pp. 399-401

Stratigos, A., Nikolaou, V., Kedicoglou, S., Antoniou, C., Stefanaki, I., Haidemenos, G., Katsambas, A.D.

Melanoma/skin cancer screening in a Mediterranean country: Results of the Euromelanoma screening day campaign in Greece

(2007) Journal of the European Academy of Dermatology and Venereology, 21 (1), pp. 56-62.

Stefanaki, I., Stratigos, A.J., Dimisianos, G., Nikolaou, V., Papadopoulos, O., Polydorou, D., Gogas, H., Tsoutsos, D., Panagiotou, P., Kanavakis, E., Antoniou, C., Katsambas, A.D.

p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants

(2007) British Journal of Dermatology, 156 (2), pp. 357-362.

Stefanaki, C., Stefanaki, K., Antoniou, C., Argyrakos, T., Patereli, A., Stratigos, A., Katsambas, A.

Cell cycle and apoptosis regulators in Spitz nevi: Comparison with melanomas and common nevi

(2007) Journal of the American Academy of Dermatology, 56 (5), pp. 815-824

Nikolaou, V., Stratigos, A.J., Antoniou, C., Sypsa, V., Stefanaki, I., Papadopoulos, O., Danopoulou, I., Hampsas, G., Plaka, M., Polydorou, D., Katsambas, A.D.

Seasonal pattern of the diagnosis of cutaneous melanoma: A hospital-based study in a Mediterranean country

(2007) International Journal of Dermatology, 46 (11), pp. 1136-1140

Stefanaki, C., Stefanaki, K., Antoniou, C., Argyrakos, T., Stratigos, A., Patereli, A., Katsambas, A.

G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas

(2008) Journal of Cutaneous Pathology, 35 (9), pp. 799-808

Nikolaou, V.A., Sypsa, V., Stefanaki, I., Gogas, H., Papadopoulos, O., Polydorou, D., Plaka, M., Tsoutsos, D., Dimou, A., Mourtzoukou, E., Korfitis, V., Hatziolou, E., Antoniou, C., Hatzakis, A., Katsambas, A., Stratigos, A.J.

Risk associations of melanoma in a Southern European population: Results of a case/control study

(2008) Cancer Causes and Control, 19 (7), pp. 671-679

Stratigos, A.J., Katsambas, A.D.

The value of screening in melanoma

(2009) Clinics in Dermatology, 27 (1), pp. 10-25

Nikolaou, V., Stratigos, A., Bafaloukos, D., Katsambas, A.

Antiangiogenic and antiapoptotic treatment in advanced melanoma

(2013) Clinics in Dermatology, 31 (3), pp. 257-263

Drakaki, E., Makropoulou, M., Serafetinides, A.A., Merlemis, N., Kalatzis, I., Sianoudis, I.A., Batsi, O., Christofidou, E., Stratigos, A.J., Katsambas, A.D., Antoniou, Ch.

Laser induced autofluorescence for diagnosis of non-melanoma skin cancer (Conference Paper)

(2015) Proceedings of SPIE – The International Society for Optical Engineering, (9447) 94470Y

Drakaki, E., Sianoudis, I.A., Zois, E.N., Makropoulou, M., Serafetinides, A.A., Dessinioti, C., Stefanaki, E., Stratigos, A.J., Antoniou, C., Katsambas, A., Christofidou, E.

Non-invasive spectroscopic techniques in the diagnosis of non-melanoma skin cancer (Conference Paper)

(2017) Journal of Physics: Conference Series, (931) 1, 012036

Antoniou, C., Katsambas A.

Guidelines for the treatment of vitiligo

(1992) Drugs, 43 (4), pp. 490-498.

Katsambas, A.D., Schulpis, K.H., Antoniou, C., Rigopoulos, D., Papakostandinou, E.D., Stratigos, J.

β-Endorphin serum levels in patients with vitiligo

(1994) Journal of the European Academy of Dermatology and Venereology, 3 (1), pp. 22-26.

Nicolaidou, E., Antoniou, C., Stratigos, A., Katsambas, A.D.

Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: A review

(2009) Journal of the American Academy of Dermatology, 60 (3), pp. 470-477

Nicolaidou, E., Antoniou, C., Miniati, A., Lagogianni, E., Matekovits, A., Stratigos, A., Katsambas, A.

Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics

(2012) Journal of the American Academy of Dermatology, 66 (6), pp. 954-958

Nicolaidou, E., Katsambas, A.D., Lotti, T.M.

Vitiligo (Book Chapter)

(2015) European Handbook of Dermatological Treatments, (3), pp. 1023- 1031

Katsambas, A.D., Nicolaidou, E.

Vitiligo classification and clinical presentations (Book Chapter)

(2017) Melasma and Vitiligo in Brown Skin, pp. 197 – 206

Rigopoulos, D., Katsambas, A., Antoniou, C., Stavrianeas, N.

Malignant tumours of the nail apparatus other than malignant melanoma

(1996) Skin Cancer, 11 (1), pp. 39-43

Rigopoulos, D., Ioannides, D., Prastitis, N., Katsambas, A.

Nail psoriasis: A combined treatment using calcipotriol cream and clobetasol propionate cream [3]

(2002) Acta Dermato-Venereologica, 82 (2), p. 140

Rigopoulos, D., Katoulis, A.C., Ioannides, D., Georgala, S., Kalogeromitros, D., Bolbasis, I., Karistinou, A., Christofidou, E., Polydorou, D., Balkou, P., Fragouli, E., Katsambas, A.D.

A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis

(2003) British Journal of Dermatology, 149 (1), pp. 151-156

Rigopoulos, D., Gregoriou, S., Katsambas, A.

Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: A double-blind study [1]

(2007) Acta Dermato-Venereologica, 87 (2), pp. 167-168

Rigopoulos, D., Rallis, E., Gregoriou, S., Larios, G., Belyayeva, Y., Gkouvi, K., Katsambas, A.

Treatment of Pseudomonas nail infections with 0.1% octenidine dihydrochloride solution

(2009) Dermatology, 218 (1), pp. 67-68

Rigopoulos, D., Gregoriou, S., Daniel III, C.R., Belyayeva, H., Larios, G., Verra, P., Stamou, C., Kontochristopoulos, G., Avgerinou, G., Katsambas, A.

Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment

(2009) Dermatology, 218 (4), pp. 338-341

Katsambas, A., Peris, K., Vena, G., Freidmann, P., Wozel, G., Daudén, E., Licu, D., Placchi, M., De La Brassinne, M.

Assessing the impact of efalizumab on nail, scalp and palmoplantar psoriasis and on quality of life: Results from a multicentre, open-label, phase IIIb/IV trial

(2009) Archives of Drug Information, 2 (4), pp. 66-70.

Rallis, E., Paparizos, V., Flemetakis, A., Katsambas, A.

Pseudomonas fingernail infection successfully treated with topical nadifloxacin in HIV-positive patients: Report of two cases

(2010) AIDS, 24 (7), pp. 1087-1088

Belyayeva, E., Gregoriou, S., Chalikias, J., Kontochristopoulos, G., Koumantaki, E., Makris, M., Koti, I., Katoulis, A., Katsambas, A., Rigopoulos, D.

The impact of nail disorders on quality of life

(2013) European Journal of Dermatology, 23 (3), pp. 366-371

Katsarou, A., Armenaka, M., Vosynioti, V., Lagogianni, E., Kalogeromitros, D., Katsambas, A.

Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis

(2009) Journal of the European Academy of Dermatology and Venereology, 23 (4), pp. 382-387

Rigopoulos, D., Kontochristopoulos, G., Kalogirou, O., Gregoriou, S., Katsambas, A.

Matting of hair: What is the role of conditioners?

(2006) Journal of the European Academy of Dermatology and Venereology, 20 (3), pp. 334-336.

Katsambas, A., Antoniou, C.

Melasma. Classification and treatment

(1995) Journal of the European Academy of Dermatology and Venereology, 4 (3), pp. 217-223

Katsambas, A.D.

Melasma

(2005) Nederlands Tijdschrift voor Dermatologie en Venereologie, 15 (3), p. 131

Dessinioti, C., Lotti, T.M., Stratigos, A.J., Damevska, K., Katsambas, A.D.

Melasma (book chapter)

(2015) European handbook of dermatological treatments, 3, pp. 613 – 619

Katsambas, A, Soura E.

Quality of life in melasma (book chapter)

(2017) Melasma and Vitiligo in Brown Skin, pp. 169-175

Dessinioti, C., Katsambas, A.

Melasma (book chapter)

(2017) Hyperpigmentation, pp. 23 – 29